Filing Details

Accession Number:
0001104659-14-047841
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-23 21:08:19
Reporting Period:
2014-06-23
Filing Date:
2014-06-23
Accepted Time:
2014-06-23 21:08:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449535 M Christopher Hall 7000 Shoreline Court, Suite 250
South San Francisco CA 94080
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-23 2,000 $0.80 2,000 No 4 M Direct
Common Stock Disposition 2014-06-23 2,000 $16.95 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2014-06-23 2,000 $0.00 2,000 $0.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
107,500 2020-03-29 No 4 M Direct
Footnotes
  1. This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 19, 2014.
  2. The option award is immediately exercisable, subject to the Issuer's right of repurchase. The option award vested as to 1/4 of the total number of shares subject to the option one year after March 15, 2010, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the option for each month of continuous service thereafter.